Evidence map›Paper›PMID 16230605›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression.

P V Choudary, M Molnar, S J Evans, H Tomita, J Z Li, M P Vawter, R M Myers, W E Bunney, H Akil, S J Watson and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 305 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
305citing papers in PubMed, 3 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

305 citing papers in PubMed, 3 syntheses or guidelines pooled it, 647 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

245 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

P V ChoudaryCenter for Neuroscience and Department of Psychiatry and Behavioral Sciences, University of California-Davis, 1544 Newton Court, Davis, CA 95616, USA.
M Molnar
S J Evans
H Tomita
J Z Li
M P Vawter
R M Myers
W E Bunney
H Akil
S J Watson
E G Jones
University of California, Irvine · USUniversity of California, Davis · USStanford University · USUniversity of Michigan–Ann Arbor · US

Funding

Project 5: High-Throughput Analysis of Gene RegulationP50MH060398 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUNNEY, WILLIAM E · 1999 to 2008
$12.7M
TISSUE SPECIFIC /INDUCIBLE REGULATION RECEPTORS /TRANSGEP01MH042251 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WATSON, STANLEY J · 1987 to 2006
$8.3M
NEUROBIOLOGICAL BRAIN ABNORMALITIES IN SCHIZOPHRENIAR01MH054844 · NIMH · UNIVERSITY OF CALIFORNIA IRVINE · PI JONES, EDWARD G · 1995 to 1999
–
NIMH NIH HHS 2P50 MH 060398-06NIMH NIH HHS MH 42251NIMH NIH HHS MH 54844NIMH NIH HHS P01 MH042251NIMH NIH HHS P01 MH 42251NIMH NIH HHS P50 MH060398
6 · The paper itself

Abstract

Abnormalities in L-glutamic acid (glutamate) and GABA signal transmission have been postulated to play a role in depression, but little is known about the underlying molecular determinants and neural mechanisms. Microarray analysis of specific areas of cerebral cortex from individuals who had suffered from major depressive disorder demonstrated significant down-regulation of SLC1A2 and SLC1A3, two key members of the glutamate/neutral amino acid transporter protein family, SLC1. Similarly, expression of L-glutamate-ammonia ligase, the enzyme that converts glutamate to nontoxic glutamine was significantly decreased. Together, these changes could elevate levels of extracellular glutamate considerably, which is potentially neurotoxic and can affect the efficiency of glutamate signaling. The astroglial distribution of the two glutamate transporters and L-glutamate-ammonia ligase strongly links glia to the pathophysiology of depression and challenges the conventional notion that depression is solely a neuronal disorder. The same cortical areas displayed concomitant up-regulation of several glutamate and GABA(A) receptor subunits, of which GABA(A)alpha1 and GABA(A)beta3 showed selectivity for individuals who had died by suicide, indicating their potential utility as biomarkers of suicidality. These findings point to previously undiscovered molecular underpinnings of the pathophysiology of major depression and offer potentially new pharmacological targets for treating depression.

Indexed as

Signal TransductionBipolar DisorderCerebral CortexExcitatory Amino Acid Transporter 1Excitatory Amino Acid Transporter 2gamma-Aminobutyric AcidGene Expression ProfilingGlutamate-Ammonia LigaseGlutamate Plasma Membrane Transport ProteinsGlutamic AcidHumansIn Situ HybridizationMajor Depressive DisorderNeurogliaOligonucleotide Array Sequence AnalysisReceptors, GABA-AExcitatory Amino Acid Transporter 1Excitatory Amino Acid Transporter 2gamma-Aminobutyric AcidGlutamate-Ammonia LigaseGlutamate Plasma Membrane Transport ProteinsGlutamic AcidReceptors, GABA-ASLC1A2 protein, humanSLC1A3 protein, human

Identifiers

PMID16230605
PMCPMC1257393
OpenAlexW2150002111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.